BSX Q4 2019 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$103B

Q4 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$2.9B+13.4% YoY

Gross Profit

$1.8B62.9% margin

Operating Income

$409M14.1% margin

Net Income

$4.0B137.6% margin

EPS (Diluted)

$2.83

QoQ Revenue Growth

+7.3%

Cash Flow

Operating Cash Flow

$692M

Free Cash Flow

$506M

Stock-Based Comp.

$157M

Balance Sheet

Total Assets

$30.6B

Total Liabilities

$16.7B

Stockholders' Equity

$13.9B

Cash & Equivalents

$217M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.9B	$2.6B	+13.4%
Gross Profit	$1.8B	$1.7B	+9.0%
Operating Income	$409M	$424M	-3.5%
Net Income	$4.0B	$386M	+935.2%

Revenue Segments

Cardiovascular

$1.2B58%

MedSurg

$878M42%

Geographic Segments

Non-US

$2.0B53%

UNITED STATES

$1.7B47%